Abstract:BACKGROUND:Despite recent reforms, distorting funding mechanisms and over-prescribing still maintain severe financial barriers to medicines access in China. Complicated and interrelated problems in the pharmaceutical sector require a common framework to be resolved as fragmented solutions do not work. We present a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and propose policy recommendations for promoting universal access to medicines in China.METHODS:Drawing on multiple sources of information, including a review of published literatures and official national data, field investigations in six provinces and interviews with key opinion leaders, this paper presents a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and proposes policy recommendations for promoting universal access to medicines in China.RESULTS:Public expenditure on medicines has been strictly controlled since the national healthcare reforms of 2009. Yet total pharmaceutical expenditure (TPE) and total health expenditure growth rates continuously outpaced the growth of gross domestic product (GDP). With 2.4% of GDP, TPE now exceeds that of most high income countries. The distorted provider and consumer incentives in the Chinese health system have not fundamentally changed. Price-setting and reimbursement mechanisms do not promote cost-effective use of medicines. Inappropriate price controls and perverse financial incentives are the un-resolved root causes of preference of originator brands for some major diseases and shortages of low-cost and low-consumption medicines. In addition, access to expensive life-saving medicines is yet systematically addressed.CONCLUSIONS:The complicated and interdependent problems interact in a way that leads to significant system problems in China, which create dual challenges that both the developing country and the developed countries are facing. To further promote access to medicines, China should speed up the re-assessment of the quality and efficacy of domestically produced generic medicines; coordinate various reforms of price determination, insurance payments, and procurement policies; address medicine shortages through comprehensive policies and legislation; establish specific mechanisms to achieve sustainable equitable access to expensive essential medicines with health technology assessment as a tool to ensure that policy and priority setting are created in a coherent and evidence-based way.

Study and Enlightenment on"Separation of Prescribing and Dispensing"in China Based on International Experiences

The Establishment and Evaluation of Foreign Pharmacist-managed Clinic

Deprescribing for Older Adults in the Community:Recent Developments and Implications for China

Research on standard management for quality and safety of outpatient prescription

Analysis of the Driving Force in the Separation of Pharmacy and Medicine

Perspective on Chinese Drugs Dispensing

Influence of “Separated Management between Medicine and Pharmacy” on Hospital Pharmaceutical Affairs Management in Beijing

A feasibility study on the implementation of dispensing fee in China

A review on international experience of implementing dispensing fee

Community pharmacy practice in China: past, present and future

Introduction of Foreign System of Expired Medicine Recycling and Its Enlightenment for China

Recognition of the current situation of clinical pharmacists in China

Investigation on pharmaceutical care barriers perceived by clinical pharmacists in secondary and tertiary hospitals in China

Innovative Pharmaceutical Service Practice of Medical Institutes in Zhejiang Area

Retrospective Study on Hospital' Pharmacy Trusteeship in China

Hospital pharmacy practice in the People's Republic of China

Problems and Reform Strategies of Medicines Distribution System in China

Significance of establishment on the classification management policy of the China prescription medicine and over-the-counter medicine based on foreign experience

Views of Pharmacists and Government Representatives Toward the Pilot Chief Pharmacist System in Chinese Hospitals: A Multicenter Exploratory Qualitative Study

A Review of Promoting Access to Medicines in China - Problems and Recommendations.

International Experiences of Response to Medicines Shortage and the Implications to China